THE REMOTE PATIENT MONITORING MARKET SIZE WAS VALUED AT USD 31 BN IN 2021 AND IS EXPECTED TO REACH USD 62 BN BY 2027, GROWING AT A CAGR OF 12.5% DURING THE FORECAST PERIOD.

Global Remote Patient Monitoring Market Size, Share, Trends, Analysis by

  1. COMPONENT: Cardiac Monitoring Devices, Respiratory Monitoring Devices, Blood Glucose Monitors, Fetal & Neonatal Monitoring Devices, Other Rpm
  2. APPLICATION: Cardiology, Endocrinology, Pulmonology, Others
  3. END-USER: Hospitals & Specialty Clinics, Homecare Settings, Ambulatory Surgical Centers, Long-Term & Acute Care Centers, Other
  4. GEOGRAPHY: North America, Europe, APAC, Latin America & Middle East & Africa

Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

335 Pages

icon-table

93 Tables

icon-chart

149 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

47 Companies

icon-market

5 Market Segment

GLOBAL REMOTE PATIENT MONITORING MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (2021) USD 30.56 BILLION
MARKET SIZE (2027) USD 62 BILLION
CAGR 12.5% (2022-2027)
BASE YEAR 2021
FORECAST YEAR 2022-2027
LARGEST MARKET North America
GEOGRAPHIC ANALYSIS North America (US, Canada), Europe (U.K, Germany, Italy, France, Spain), APAC (China, Japan, India, South Korea, Australia), Latin America (Brazil, Mexico, Argentina) & MEA (Turkey, Saudi Arabia, South Africa)

INDUSTRY OVERVIEW 

The global remote patient monitoring market was valued at USD 30 billion in 2021 and is expected to reach USD 62 billion, growing at a CAGR of 12.5% during the forecast period. According to the Arizton market research report, the market is expected to grow due to an increase in demand for remote patient monitoring systems and devices due to the COVID-19 pandemic.

ANALYSTS' VIEWPOINT

The global remote patient monitoring market is expected to grow at a remarkable growth due to technological improvements, a greater focus on public health, more consumer awareness of the benefits of RPM, and lower prices. Moreover, several traditional medical devices manufacturers are gradually expanding their product portfolios and focusing on launching remote patient monitoring devices integrated with advanced technologies, such as the Internet of Things.

Remote patient monitoring is achieved by using digital technologies to monitor and capture medical health-related data from patients and electronically transmit the information to healthcare providers for assessment, and, when necessary, recommendations and instructions are provided. RPM reduces the number of readmissions in the medical requirement, hospitalizations, and duration of stay in the hospital, which leads to improved quality of life and contain costs.

ACQUISITIONS AND PRODUCT LAUNCHES TO INCREASE MARKET SHARE

  • In August 2020, Stasis Labs introduced a mobile-connected remote patient monitoring technology in hospitals and outpatient settings in the US. The company's Stasis system monitors important vital parameters in its functioning.
  • In July 2020, Philips and BioIntelliSense teamed together to improve remote patient monitoring systems for at-risk patients from the hospital to their homes. Philips has added the BioIntelliSense sensor to the device for remotely usage.
  • Phillips launched Tempus ALS, a pre-hospital wireless monitoring solution, in the US in July 2020. It includes a remote professional defibrillator (Tempus LS-Manual) and portable vital signs monitor (Tempus Pro).
  • In March 2020, the US government announced a financing authorization for a remote health care initiative of USD 500 million over ten years. The government's funding implies that the US government is interested in incorporating RPM into its healthcare system.
  • T-Mobile delivered 5G in the Miami Veterans Affairs (VA) Healthcare System in February 2021 to improve telemedicine capabilities.
  • Verizon's HIPAA-compliant virtual care platform BlueJeans Telehealth was released in April 2021.
  • Boost Mobile, owned by Dish Network, collaborated with digital health startup K Health in May 2021 to offer free telehealth services to users of its Unlimited Plus plan.

INCREASING PREVALENCE OF CHRONIC DISEASES

Chronic diseases and other related disorders accounted for nearly three-quarters of all deaths worldwide in 2020. According to the World Health Organization, 71% of deaths due to ischemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes occur in developing countries. In developing nations, the number of persons living with diabetes is expected to be more than double by 2025, from 84 million in 1995 to 228 million.

According to the Centers for Disease Control and Prevention, six out of ten adults in the US suffer from a chronic illness. Chronic diseases are expected to afflict 164 million people in the US by 2025, accounting for over half that is 49% of the population. Multidisciplinary teams in primary care and public health are superior at preventing and managing chronic disease. According to Project HOPE: The People-to-People Health Foundation, Inc., the number of persons with persistent mental disorders is expected to rise from 30 million to 47 million by 2023. Almost every prevalent chronic illness is expected to see similar rates.

Rising Demand due to COVID-19 Pandemic

The need for remote patient monitoring devices has been steadily increasing as the number of COVID-19 patients in hospitals and medical facilities worldwide has increased. The demand for remote patient monitoring equipment has increased dramatically, particularly among patients with chronic conditions. The increase in awareness regarding COVID-19 and increasing worry to get infected because of a hospital visit is driving the global remote patient monitoring market growth.

REMOTE PATIENT MONITORING MARKET SEGMENT

The Devices and Software segment accounted for the largest share in the global remote patient monitoring market. With the emergence of connected cardiac implants, cardiology was one of the first specialties to incorporate RPM. Cardiology practices are now particularly well-positioned to gain the short and long-term benefits associated with the progression of RPM services, technology, and regulation. The cardiac monitoring market is further propelled by innovative product characteristics, as well as the increased need and demand for virtual care solutions in the COVID-19 era. The cardiac monitor segment accounted for the maximum share in the remote patient monitoring market. For instance, according to CDC, 30.3 million US adults were identified with heart disorders in 2018. Thus, the high prevalence of cardiac disorder is expected to drive the segment.

Despite RPM's early popularity, some people are still unaware of the concept. RPM is a covered service that uses digital technologies and electronic monitoring to encourage patients to take a more active role in their health while also allowing practitioners to collect crucial patient data in between in-office appointments. RPM has various important applications in cardiology, including hypertension management, medication management, and weight for congestive heart failure patients.

The application of RPM devices is more prevalent in cardiology treatment as compared to pulmonology and endocrinology. The cardiology RPM programs enable cardiologists to streamline treatment and enhance their time management, which are two of the most significant benefits identified by cardiologists. Cardiologists can support a large patient base while lowering stress associated with burnout by tracking crucial patient data more easily and minimizing the frequency of in-office visits for some patients. RPM also improves the chances of detecting and resolving an impending health crisis while also giving practitioners greater insight into the patient's lifestyle and triggers, allowing them to make informed treatment modifications.

Hospitals & specialty clinics contribute maximum revenue share to the market as RPMs are primarily used in hospitals & specialty clinics. The use of RPM and a centralized virtual care team at hospitals & clinics has significantly reduced the hospital readmission rate and has lowered overall acute care resource utilization among acutely ill patients. Continuous remote monitoring of hospitalized patients treated in general medical settings not only improves outcomes but also increases accuracy and reduces the burden of obtaining and documenting patients' vital signs on overworked and under-resourced staff by automating a task that is to be performed several times per day for each patient when integrated into the electronic health record (EHR). All these factors propel the adoption of RPM devices and software in hospitals and clinics, thus further boosting the market growth.

GEOGRAPHIC OVERVIEW

North America accounted for a significant 40% of the global market for remote patient monitoring market share in 2021. The presence of substantial competitors and their growth strategies are the main factors driving the North American market. The industry is driven by rising healthcare spending and increased awareness about the benefits of sickness prevention. An increase in heart ailments, sedentary lifestyles, and the deployment of e-health in some rural areas of North America is expected to drive the market growth. The government's involvement in introducing telehealth technology to rural areas and the existence of significant corporations in the area all contribute to the market expansion.

COMPETITIVE LANDSCAPE

With many top companies in the global market and several small players in regional markets, the global remote patient monitoring market is somewhat fragmented. The major competitors in the market are focusing their efforts on reducing the size of the remote patient monitoring market. These companies are also attempting to increase their market share by launching new goods and forming collaborations with other market participants. As a result, these factors are expected to propel the remote patient monitoring market growth.

Resideo Technologies, Medtronic, Philips Healthcare, and ResMed are among the leading companies for Devices and Software. Withings, MedM, iHealthUnifiedcare, and Qardio are among the top companies in the industry.

100Plus, A&D Medical, Abbott, Altumview Systems, Biotronik, Boston Scientific, Bardy Diagnostics, Cardiomo, Cardiologs, Dragerwerk AG, F. Hoffmann-La Roche Ltd, Fluxion Biosciences, GE Healthcare, GrandCare Systems, Masimo Corporation, Medopad, Nihon Kohden, Omron Healthcare, OSPLabs, Qualcomm Technologies, Senseonics, VitalConnect, are among the leading players.

Frequently Asked Questions

What is the size of the remote patient monitoring market?

The remote patient monitoring market was valued at USD 30.56 BN in 2021 and is expected to reach USD 61.78 BN by 2027.

What is the remote patient monitoring system market growth?

The remote patient monitoring market is expected to grow at a CAGR of 12.5% during 2021-2027.

Who are the leading players in the remote patient monitoring market?

Resideo Technologies, Medtronic, Philips Healthcare, and ResMed are among the leading companies in the global remote patient monitoring market for Devices and Software.

Which region will dominate the global remote patient monitoring market landscape?

North America remains the dominating market for remote patient monitoring due to the rising healthcare spending in the reason.

What is the key strategy focused by remote patient monitoring companies to increase their market share?

Mergers & Acquisitions are the key strategies that the companies are focusing on in the global remote patient monitoring devices industry.

Download Free Sample

The global remote patient monitoring market to grow at a CAGR of 12.5% during 2021-2027.

The report considers the present scenario of the remote patient monitoring market and its market dynamics for 2022−2027. It covers a detailed overview of several growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyses leading companies and several other prominent companies operating in the industry.

Top Players

  • Medtronic
  • Philips Healthcare
  • ResMed

Other Prominent Players

  • Resideo
  • Honeywell
  • LST (LifeScience Technologies)
  • Coforge
  • Withings
  • MedM
  • iHealthUnifiedcare
  • Qardio
  • 100-Plus
  • A&D
  • Abbott
  • AltumView Systems
  • Biotronik
  • Boston Scientific
  • Bardy Diagnostics
  • Cardiomo
  • Cardiologs
  • Dragerwerk AG
  • Hoffmann-La Roche
  • GE Healthcare
  • GrandCare
  • Masimo Corporation
  • Medopad
  • Nihon Kohden
  • Omron Healthcare
  • OSPLabs
  • Smiths Medical
  • Spacelabs
  • Senseonics
  • TeleMedCare
  • VitalConnect
  • Vitls
  • Modicare
  • Hillrom
  • Vivify Health
  • ACL Digital
  • Dexcom
  • iRhythm Technologies
  • Vivalink
  • Biobeat
  • CareValidate
  • Biofourmis
  • CAREMINDr
  • Datos Health

Component:

  • Devices and Software
    • Cardiac Monitoring Devices
      • Electrocardiographs (ECGs)
      • Cardiac monitors
      • Blood Pressure Monitor
      • Others
    • Respiratory Monitoring Devices
      • Apnea monitor
      • Pulse Oximeters
      • Others
    • Blood Glucose Monitors
      • Continuous Blood Glucose Monitors (CGM)
    • Fetal & neonatal monitoring devices
    • Other RPM
  • Service 

Application

  • Cardiology
  • Endocrinology
  • Pulmonology
  • Others

End-User

  • Hospitals & Specialty Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Long-term & Acute Care Centers
  • Other

Geography

  • North America
    • US
    • Canada
  • Europe
    • K
    • Germany
    • Italy
    • France
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • Turkey
    • Saudi Arabia
    • South Africa

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY COMPONENT

4.3.2 MARKET SEGMENTATION BY APPLICATION

4.3.3 MARKET SEGMENTATION BY END-USER

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

7.1.1 COVID-19 IMPACT ON REMOTE PATIENT MONITORING MARKET

8 MARKET OPPORTUNITIES & TRENDS

8.1 INCREASING ROLE OF IOT IN REMOTE MONITORING & HEALTHCARE APPLICATIONS

8.2 PARADIGM SHIFT TOWARD HOME-BASED HEALTHCARE DEVICES

8.3 TELEMEDICINE USHERING NEW OPPORTUNITIES IN REMOTE MONITORING

9 MARKET GROWTH ENABLERS

9.1 AGING POPULATION VULNERABLE TO CHRONIC DISEASES

9.2 RISING WEARABLE MEDICAL TECHNOLOGY INNOVATIONS

9.3 GROWING USE OF RPM TO PROACTIVELY MONITOR & IMPROVE PATIENT ENGAGEMENT

9.4 INCREASED DEMAND FOR REMOTE MONITORING DUE TO COVID-19

10 MARKET GROWTH RESTRAINTS

10.1 LOW AWARENESS OF REMOTE MONITORING IN DEVELOPING COUNTRIES

10.2 LACK OF DATA ACCURACY

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW

11.2 MARKET SIZE & FORECAST

11.2.1 MARKET SHARE BY COMPONENT

11.2.2 MARKET SHARE BY DEVICES & SOFTWARE

11.2.3 MARKET SHARE BY APPLICATION

11.2.4 MARKET SHARE BY END-USER

11.2.5 MARKET BY GEOGRAPHY

11.3 FIVE FORCES ANALYSIS

11.3.1 THREAT OF NEW ENTRANTS

11.3.2 BARGAINING POWER OF SUPPLIERS

11.3.3 BARGAINING POWER OF BUYERS

11.3.4 THREAT OF SUBSTITUTES

11.3.5 COMPETITIVE RIVALRY

12 COMPONENT

12.1 MARKET SNAPSHOT & GROWTH ENGINE

13 DEVICES & SOFTWARE

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 CARDIAC MONITORING DEVICES

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 CARDIAC MONITORING DEVICES: MARKET BY GEOGRAPHY

13.4 ELECTROCARDIOGRAPHS (ECGS)

13.4.1 MARKET OVERVIEW

13.4.2 ELECTROCARDIOGRAM (ECG): MARKET SIZE & FORECAST

13.5 CARDIAC MONITORS

13.5.1 MARKET OVERVIEW

13.5.2 CARDIAC MONITORS: MARKET SIZE & FORECAST

13.6 BLOOD PRESSURE MONITORS

13.6.1 MARKET OVERVIEW

13.6.2 MARKET SIZE & FORECAST

13.7 OTHER CARDIAC MONITORING DEVICES

13.7.1 MARKET OVERVIEW

13.7.2 MARKET SIZE & FORECAST

13.8 RESPIRATORY MONITORING DEVICES

13.8.1 MARKET OVERVIEW

13.8.2 MARKET SIZE & FORECAST

13.8.3 RESPIRATORY MONITORING DEVICES: MARKET BY GEOGRAPHY

13.9 APNEA MONITORS

13.9.1 MARKET OVERVIEW

13.9.2 MARKET SIZE & FORECAST

13.10 PULSE OXIMETERS

13.10.1 MARKET OVERVIEW

13.10.2 MARKET SIZE & FORECAST

13.11 OTHER RESPIRATORY MONITORING DEVICES

13.11.1 MARKET OVERVIEW

13.11.2 MARKET SIZE & FORECAST

13.12 BLOOD GLUCOSE MONITORS

13.12.1 MARKET OVERVIEW

13.12.2 MARKET SIZE & FORECAST

13.12.3 BLOOD GLUCOSE MONITORS: MARKET BY GEOGRAPHY

13.13 FETAL & NEONATAL MONITORING DEVICES

13.13.1 MARKET OVERVIEW

13.13.2 MARKET SIZE & FORECAST

13.13.3 FETAL & NEONATAL MONITORING DEVICES: MARKET BY GEOGRAPHY

13.14 OTHER RPM DEVICES

13.14.1 MARKET OVERVIEW

13.14.2 MARKET SIZE & FORECAST

13.14.3 OTHER RPM DEVICES: MARKET BY GEOGRAPHY

13.15 SERVICES

13.15.1 MARKET OVERVIEW

13.15.2 MARKET SIZE & FORECAST

13.15.3 REMOTE PATIENT MONITORING SERVICES: MARKET BY GEOGRAPHY

14 APPLICATION

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 CARDIOLOGY

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 CARDIOLOGY REMOTE PATIENT MONITORING: MARKET BY GEOGRAPHY

14.4 PULMONOLOGY

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 PULMONOLOGY REMOTE PATIENT MONITORING: MARKET BY GEOGRAPHY

14.5 ENDOCRINOLOGY

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 REMOTE ENDOCRINOLOGY PATIENT MONITORING: MARKET BY GEOGRAPHY

14.6 OTHERS

14.6.1 MARKET OVERVIEW

14.6.2 MARKET SIZE & FORECAST

14.6.3 OTHER: MARKET BY GEOGRAPHY

15 END-USER

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 HOSPITALS & SPECIALTY CLINICS

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 HOSPITALS & SPECIALTY CLINICS: MARKET BY GEOGRAPHY

15.4 HOMECARE SETTINGS

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 HOMECARE SETTINGS: MARKET BY GEOGRAPHY

15.5 AMBULATORY SURGICAL CENTERS

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.5.3 AMBULATORY SURGICAL CENTERS: MARKET BY GEOGRAPHY

15.6 LONG-TERM & ACUTE CARE CENTERS

15.6.1 MARKET OVERVIEW

15.6.2 MARKET SIZE & FORECAST

15.6.3 LONG-TERM & ACUTE CARE CENTERS: MARKET BY GEOGRAPHY

15.7 OTHERS

15.7.1 MARKET OVERVIEW

15.7.2 MARKET SIZE & FORECAST

15.7.3 OTHERS: MARKET BY GEOGRAPHY

16 GEOGRAPHY

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.3 NORTH AMERICA: COMPONENT SEGMENTATION (REVENUE)

17.4 NORTH AMERICA: APPLICATION SEGMENTATION (REVENUE)

17.5 NORTH AMERICA: END-USER SEGMENTATION (REVENUE)

17.6 NORTH AMERICA: KEY COUNTRIES

17.6.1 US: MARKET SIZE & FORECAST

17.6.2 CANADA: MARKET SIZE & FORECAST

18 EUROPE

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 EUROPE: COMPONENT SEGMENTATION (REVENUE)

18.4 EUROPE: APPLICATION SEGMENTATION (REVENUE)

18.5 EUROPE: END-USER SEGMENTATION (REVENUE)

18.7 EUROPE: KEY COUNTRIES

18.7.1 GERMANY: MARKET SIZE & FORECAST

18.7.2 UK: MARKET SIZE & FORECAST

18.7.3 FRANCE: MARKET SIZE & FORECAST

18.7.4 SPAIN: MARKET SIZE & FORECAST

18.7.5 ITALY: MARKET SIZE & FORECAST

19 APAC

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 APAC: COMPONENT SEGMENTATION (REVENUE)

19.4 APAC: APPLICATION SEGMENTATION (REVENUE)

19.5 APAC: END-USER SEGMENTATION (REVENUE)

19.6 APAC: KEY COUNTRIES

19.6.1 CHINA: MARKET SIZE & FORECAST

19.6.2 JAPAN: MARKET SIZE & FORECAST

19.6.3 INDIA: MARKET SIZE & FORECAST

19.6.4 AUSTRALIA: MARKET SIZE & FORECAST

19.6.5 SOUTH KOREA: MARKET SIZE & FORECAST

20 LATIN AMERICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 LATIN AMERICA: COMPONENT SEGMENTATION (REVENUE)

20.4 LATIN AMERICA: APPLICATION SEGMENTATION (REVENUE)

20.5 LATIN AMERICA: END-USER SEGMENTATION (REVENUE)

20.6 LATIN AMERICA: KEY COUNTRIES

20.6.1 MEXICO: MARKET SIZE & FORECAST

20.6.2 ARGENTINA: MARKET SIZE & FORECAST

20.6.3 BRAZIL: MARKET SIZE & FORECAST

21 MIDDLE EAST & AFRICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 MIDDLE EAST & AFRICA: COMPONENT SEGMENTATION (REVENUE)

21.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION (REVENUE)

21.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION (REVENUE)

21.6 MIDDLE EAST & AFRICA: KEY COUNTRIES

21.6.1 TURKEY: MARKET SIZE & FORECAST

21.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST

21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

22.1 MARKET SHARE ANALYSIS

22.1.1 MEDTRONIC

22.1.2 PHILIPS HEALTHCARE

22.1.3 RESMED

22.2 MARKET SHARE ANALYSIS OVERVIEW BY SERVICES

22.2.1 WITHINGS

22.2.2 MEDM

22.2.3 IHEALTHUNIFIEDCARE

22.2.4 QARDIO

23 KEY VENDORS

23.1 MEDTRONIC

23.1.1 BUSINESS OVERVIEW

23.1.2 PRODUCT OFFERING

23.2 PHILIPS HEALTHCARE

23.2.1 BUSINESS OVERVIEW

23.2.2 PRODUCT OFFERING

23.3 RESMED

23.3.1 BUSINESS OVERVIEW

23.3.2 PRODUCT OFFERING

24 OTHER PROMINENT VENDORS

24.1 RESIDEO TECHNOLOGIES

24.1.1 BUSINESS OVERVIEW

24.1.2 PRODUCT OFFERING

24.2 HONEYWELL INTERNATIONAL

24.2.1 BUSINESS OVERVIEW

24.3 LIFESCIENCE TECHNOLOGIES

24.3.1 BUSINESS OVERVIEW

24.3.2 PRODUCT OFFERING

24.4 COFORGE

24.4.1 BUSINESS OVERVIEW

24.4.2 PRODUCT OFFERING

24.5 WITHINGS

24.5.1 BUSINESS OVERVIEW

24.5.2 PRODUCT OFFERING

24.6 MEDM

24.6.1 BUSINESS OVERVIEW

24.6.2 PRODUCT OFFERING

24.7 IHEALTHUNIFIEDCARE

24.7.1 BUSINESS OVERVIEW

24.7.2 PRODUCT OFFERINGS

24.8 QARDIO

24.8.1 BUSINESS OVERVIEW

24.8.2 PRODUCT OFFERINGS

24.9 100-PLUS

24.9.1 BUSINESS OVERVIEW

24.9.2 PRODUCT OFFERINGS

24.10 A&D COMPANY

24.10.1 BUSINESS OVERVIEW

24.10.2 PRODUCT OFFERINGS

24.11 ABBOTT

24.11.1 BUSINESS OVERVIEW

24.11.2 PRODUCT OFFERINGS

24.12 ALTUMVIEW SYSTEMS

24.12.1 BUSINESS OVERVIEW

24.12.2 PRODUCT OFFERINGS

24.13 BIOTRONIK

24.13.1 BUSINESS OVERVIEW

24.13.2 PRODUCT OFFERING

24.14 BOSTON SCIENTIFIC

24.14.1 BUSINESS OVERVIEW

24.14.2 PRODUCT OFFERINGS

24.15 BARDY DIAGNOSTICS

24.15.1 BUSINESS OVERVIEW

24.15.2 PRODUCT OFFERINGS

24.16 CARDIOMO CARE

24.16.1 BUSINESS OVERVIEW

24.16.2 PRODUCT OFFERINGS

24.17 CARDIOLOGS

24.17.1 BUSINESS OVERVIEW

24.17.2 PRODUCT OFFERINGS

24.18 DRAGERWERK AG

24.18.1 BUSINESS OVERVIEW

24.18.2 PRODUCT OFFERINGS

24.19 F. HOFFMANN-LA ROCHE

24.19.1 BUSINESS OVERVIEW

24.19.2 PRODUCT OFFERINGS

24.20 GE HEALTHCARE

24.20.1 BUSINESS OVERVIEW

24.20.2 PRODUCT OFFERINGS

24.21 GRANDCARE SYSTEMS

24.21.1 BUSINESS OVERVIEW

24.21.2 PRODUCT OFFERINGS

24.22 MASIMO CORPORATION

24.22.1 BUSINESS OVERVIEW

24.22.2 PRODUCT OFFERINGS

24.23 MEDOPAD

24.23.1 BUSINESS OVERVIEW

24.23.2 PRODUCT OFFERINGS

24.24 NIHON KOHDEN

24.24.1 BUSINESS OVERVIEW

24.24.2 PRODUCT OFFERINGS

24.25 OMRON HEALTHCARE

24.25.1 BUSINESS OVERVIEW

24.25.2 PRODUCT OFFERINGS

24.26 OSPLABS

24.26.1 BUSINESS OVERVIEW

24.26.2 PRODUCT OFFERINGS

24.27 SMITHS MEDICAL

24.27.1 BUSINESS OVERVIEW

24.27.2 PRODUCT OFFERINGS

24.28 SPACELABS HEALTHCARE

24.28.1 BUSINESS OVERVIEW

24.28.2 PRODUCT OFFERINGS

24.29 SENSEONICS

24.29.1 BUSINESS OVERVIEW

24.29.2 PRODUCT OFFERINGS

24.30 TELEMEDCARE

24.30.1 BUSINESS OVERVIEW

24.30.2 PRODUCT OFFERINGS

24.31 VITALCONNECT

24.31.1 BUSINESS OVERVIEW

24.31.2 PRODUCT OFFERINGS

24.32 VITLS

24.32.1 BUSINESS OVERVIEW

24.32.2 PRODUCT OFFERINGS

24.33 MODICARE

24.33.1 BUSINESS OVERVIEW

24.33.2 PRODUCT OFFERINGS

24.34 HILLROM

24.34.1 BUSINESS OVERVIEW

24.34.2 PRODUCT OFFERINGS

24.35 VIVIFY HEALTH

24.35.1 BUSINESS OVERVIEW

24.35.2 PRODUCT OFFERING

24.36 ACL DIGITAL

24.36.1 BUSINESS OVERVIEW

24.36.2 PRODUCT OFFERINGS

24.37 DEXCOM

24.37.1 BUSINESS OVERVIEW

24.37.2 PRODUCT OFFERING

24.38 IRHYTHM TECHNOLOGIES

24.38.1 BUSINESS OVERVIEW

24.38.2 PRODUCT OFFERING

24.39 VIVALINK

24.39.1 BUSINESS OVERVIEW

24.39.2 PRODUCT OFFERING

24.40 BIOBEAT

24.40.1 BUSINESS OVERVIEW

24.40.2 PRODUCT OFFERINGS

24.41 CAREVALIDATE

24.41.1 BUSINESS OVERVIEW

24.41.2 PRODUCT OFFERINGS

24.42 BIOFOURMIS

24.42.1 BUSINESS OVERVIEW

24.42.2 PRODUCT OFFERING

24.43 CAREMINDR

24.43.1 BUSINESS OVERVIEW

24.43.2 PRODUCT OFFERING

24.44 DATOS HEALTH

24.44.1 BUSINESS OVERVIEW

24.44.2 PRODUCT OFFERINGS

25 REPORT SUMMARY

25.1 KEY TAKEAWAYS

25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

26.1 MARKET BY GEOGRAPHY

26.2 MARKET BY COMPONENTS

26.2.1 MARKET BY DEVICES & SOFTWARE

26.2.2 MARKET BY CARDIAC MONITORING DEVICES

26.2.3 MARKET BY RESPIRATORY MONITORING DEVICES

26.3 MARKET BY APPLICATION

26.4 MARKET BY END-USER

26.5 NORTH AMERICA: BY COMPONENTS

26.5.1 DEVICES & SOFTWARE

26.5.2 CARDIAC MONITORING DEVICES

26.5.3 RESPIRATORY MONITORING DEVICES

26.6 NORTH AMERICA: BY APPLICATION

26.7 NORTH AMERICA: BY END-USER

26.8 EUROPE: BY COMPONENTS

26.8.1 DEVICES & SOFTWARE

26.8.2 CARDIAC MONITORING DEVICES

26.8.3 RESPIRATORY MONITORING DEVICES

26.9 EUROPE: BY APPLICATION

26.10 EUROPE: BY END-USER

26.11 APAC: BY COMPONENTS

26.11.1 DEVICES & SOFTWARE

26.11.2 CARDIAC MONITORING DEVICES

26.11.3 RESPIRATORY MONITORING DEVICES

26.12 APAC: BY APPLICATION

26.13 APAC: BY END-USER

26.14 LATIN AMERICA: BY COMPONENTS

26.14.1 DEVICES & SOFTWARE

26.14.2 CARDIAC MONITORING DEVICES

26.14.3 RESPIRATORY MONITORING DEVICES

26.15 LATIN AMERICA: BY APPLICATION

26.16 LATIN AMERICA: BY END-USER

26.17 MIDDLE EAST & AFRICA: BY COMPONENTS

26.17.1 DEVICES & SOFTWARE

26.17.2 CARDIAC MONITORING DEVICES

26.17.3 RESPIRATORY MONITORING DEVICES

26.18 MIDDLE EAST & AFRICA: BY APPLICATION

26.19 MIDDLE EAST & AFRICA: BY END-USER

27 APPENDIX

27.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL REMOTE PATIENT MONITORING MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 REMOTE PATIENT MONITORING SYSTEMS WORKING STRUCTURE

EXHIBIT 4 IMPACT OF INCREASING ROLE OF IOT IN REMOTE MONITORING & HEALTHCARE APPLICATIONS

EXHIBIT 5 WAYS HEALTHCARE IOT & REMOTE PATIENT MONITORING ARE TRANSFORMING CARE DELIVERY

EXHIBIT 6 IMPACT OF THE PARADIGM SHIFT TOWARD HOME-BASED HEALTHCARE DEVICES

EXHIBIT 7 IMPACT OF TELEMEDICINE USHERING NEW OPPORTUNITIES IN REMOTE MONITORING

EXHIBIT 8 IMPACT OF AGING POPULATION VULNERABLE TO CHRONIC DISEASES

EXHIBIT 9 IMPACT OF RISING WEARABLE MEDICAL TECHNOLOGY INNOVATIONS

EXHIBIT 10 IMPACT OF GROWING USE OF RPM TO PROACTIVELY MONITOR & IMPROVE PATIENT ENGAGEMENT

EXHIBIT 11 IMPACT OF INCREASING DEMAND FOR REMOTE MONITORING CAPABILITIES DUE TO COVID-19

EXHIBIT 12 IMPACT OF LOW AWARENESS OF REMOTE MONITORING IN DEVELOPING COUNTRIES

EXHIBIT 13 IMPACT OF LACK OF DATA ACCURACY

EXHIBIT 14 DATA QUALITY CHALLENGES DURING PGHD MANAGEMENT

EXHIBIT 15 GLOBAL REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 16 GLOBAL REMOTE PATIENT MONITORING MARKET BY COMPONENT

EXHIBIT 17 GLOBAL REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE

EXHIBIT 18 GLOBAL REMOTE PATIENT MONITORING MARKET BY APPLICATION

EXHIBIT 19 GLOBAL REMOTE PATIENT MONITORING MARKET BY END-USER

EXHIBIT 20 GLOBAL REMOTE PATIENT MONITORING MARKET BY GEOGRAPHY

EXHIBIT 21 FIVE FORCES ANALYSIS 2021

EXHIBIT 22 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 23 INCREMENTAL GROWTH BY DEVICES & SOFTWARE 2021 & 2027

EXHIBIT 24 GLOBAL REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE

EXHIBIT 25 GLOBAL REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE: INCREMENTAL GROWTH

EXHIBIT 26 GLOBAL REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE: ABSOLUTE GROWTH

EXHIBIT 27 GLOBAL REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 28 GLOBAL REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021–2027 ($ BILLION)

EXHIBIT 29 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 30 GLOBAL ECG REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 31 GLOBAL REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORS 2021–2027 ($ BILLION)

EXHIBIT 32 GLOBAL REMOTE BLOOD PRESSURE MONITORS MARKET 2021–2027 ($ BILLION)

EXHIBIT 33 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER CARDIAC MONITORING DEVICES 2021–2027 ($ BILLION)

EXHIBIT 34 GLOBAL REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 35 GLOBAL REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021–2027 ($ BILLION)

EXHIBIT 36 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 37 GLOBAL REMOTE PATIENT MONITORING MARKET BY APNEA MONITORS 2021–2027 ($ BILLION)

EXHIBIT 38 GLOBAL REMOTE PATIENT MONITORING MARKET BY PULSE OXIMETERS 2021–2027 ($ BILLION)

EXHIBIT 39 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER RESPIRATORY MONITORING DEVICES 2021–2027 ($ BILLION)

EXHIBIT 40 GLOBAL REMOTE PATIENT MONITORING MARKET BY BLOOD GLUCOSE MONITORS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 41 GLOBAL REMOTE PATIENT MONITORING MARKET BY BLOOD GLUCOSE MONITORS 2021–2027 ($ BILLION)

EXHIBIT 42 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 43 GLOBAL REMOTE FETAL & NEONATAL MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 44 GLOBAL REMOTE FETAL & NEONATAL MONITORING DEVICES MARKET 2021–2027 ($ BILLION)

EXHIBIT 45 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 46 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER RPM DEVICES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 47 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER RPM DEVICES 2021–2027 ($ BILLION)

EXHIBIT 48 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 49 GLOBAL REMOTE PATIENT MONITORING MARKET BY SERVICES 2021–2027 ($ BILLION)

EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 51 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 52 GLOBAL REMOTE PATIENT MONITORING MARKET BY APPLICATION

EXHIBIT 53 GLOBAL REMOTE PATIENT MONITORING MARKET BY APPLICATION: INCREMENTAL GROWTH

EXHIBIT 54 GLOBAL REMOTE PATIENT MONITORING MARKET BY APPLICATION: ABSOLUTE GROWTH

EXHIBIT 55 GLOBAL REMOTE CARDIOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 56 GLOBAL REMOTE CARDIOLOGY PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 57 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 58 GLOBAL REMOTE PULMONOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 59 GLOBAL REMOTE PULMONOLOGY PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 60 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 61 GLOBAL REMOTE ENDOCRINOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 62 GLOBAL REMOTE ENDOCRINOLOGY PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 64 GLOBAL OTHER REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 65 GLOBAL OTHER REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 67 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 68 GLOBAL REMOTE PATIENT MONITORING MARKET BY END-USER

EXHIBIT 69 GLOBAL REMOTE PATIENT MONITORING MARKET BY END-USER: INCREMENTAL GROWTH

EXHIBIT 70 GLOBAL REMOTE PATIENT MONITORING MARKET BY HOSPITALS & SPECIALTY CLINICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 71 GLOBAL REMOTE PATIENT MONITORING MARKET BY HOSPITALS & SPECIALTY CLINICS 2021–2027 ($ BILLION)

EXHIBIT 72 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 73 GLOBAL REMOTE PATIENT MONITORING MARKET BY HOMECARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 74 GLOBAL REMOTE PATIENT MONITORING MARKET BY HOMECARE SETTINGS 2021–2027 ($ BILLION)

EXHIBIT 75 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 76 GLOBAL REMOTE PATIENT MONITORING MARKET BY AMBULATORY SURGICAL CENTERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 77 GLOBAL REMOTE PATIENT MONITORING MARKET BY AMBULATORY SURGICAL CENTERS 2021–2027 ($ BILLION)

EXHIBIT 78 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 79 GLOBAL REMOTE PATIENT MONITORING MARKET BY LONG-TERM & ACUTE CARE CENTERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 80 GLOBAL REMOTE PATIENT MONITORING MARKET BY LONG-TERM & ACUTE CARE CENTERS 2021–2027 ($ BILLION)

EXHIBIT 81 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 82 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER END-USERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 83 GLOBAL REMOTE PATIENT MONITORING MARKET BY OTHER END-USERS 2021–2027 ($ BILLION)

EXHIBIT 84 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027 ($ BILLION)

EXHIBIT 85 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 86 GLOBAL REMOTE PATIENT MONITORING MARKET BY GEOGRAPHY

EXHIBIT 87 GLOBAL REMOTE PATIENT MONITORING MARKET BY REGION: INCREMENTAL GROWTH

EXHIBIT 88 GLOBAL REMOTE PATIENT MONITORING MARKET BY REGION: ABSOLUTE GROWTH

EXHIBIT 89 NORTH AMERICA REMOTE PATIENT MONITORING MARKET: KEY COUNTRIES ($ BILLION)

EXHIBIT 90 NORTH AMERICA REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 91 NORTH AMERICA REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 92 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 93 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 94 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 95 INCREMENTAL GROWTH BY KEY COUNTRIES 2021 & 2027

EXHIBIT 96 REMOTE PATIENT MONITORING MARKET IN US. 2021–2027 ($ BILLION)

EXHIBIT 97 REMOTE PATIENT MONITORING MARKET IN CANADA 2021–2027 ($ BILLION)

EXHIBIT 98 EUROPE REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 99 EUROPE REMOTE PATIENT MONITORING MARKET: KEY COUNTRIES ($MILLION)

EXHIBIT 100 EUROPE REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 101 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 102 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 103 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 104 INCREMENTAL GROWTH BY EUROPE 2021 & 2027

EXHIBIT 105 REMOTE PATIENT MONITORING MARKET IN GERMANY 2021–2027 ($ BILLION)

EXHIBIT 106 REMOTE PATIENT MONITORING MARKET IN UK 2021–2027 ($ BILLION)

EXHIBIT 107 REMOTE PATIENT MONITORING MARKET IN FRANCE 2021–2027 ($ BILLION)

EXHIBIT 108 REMOTE PATIENT MONITORING MARKET IN SPAIN 2021–2027 ($ BILLION)

EXHIBIT 109 REMOTE PATIENT MONITORING MARKET IN ITALY 2021–2027 ($ BILLION)

EXHIBIT 110 APAC REMOTE PATIENT MONITORING MARKET: KEY COUNTRIES ($BILLION)

EXHIBIT 111 APAC REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 112 APAC REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 113 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 114 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 115 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 116 INCREMENTAL GROWTH BY APAC 2021 & 2027

EXHIBIT 117 REMOTE PATIENT MONITORING MARKET IN CHINA 2021–2027 ($ BILLION)

EXHIBIT 118 REMOTE PATIENT MONITORING MARKET IN JAPAN 2021–2027 ($ BILLION)

EXHIBIT 119 REMOTE PATIENT MONITORING MARKET IN INDIA 2021–2027 ($ BILLION)

EXHIBIT 120 DIGITAL HEALTH APPLICATIONS IN AUSTRALIA

EXHIBIT 121 REMOTE PATIENT MONITORING MARKET IN AUSTRALIA 2021–2027 ($ BILLION)

EXHIBIT 122 REMOTE PATIENT MONITORING MARKET IN SOUTH KOREA 2021–2027 ($ BILLION)

EXHIBIT 123 LATIN AMERICA REMOTE PATIENT MONITORING MARKET: KEY COUNTRIES ($ BILLION)

EXHIBIT 124 LATIN AMERICA REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 125 LATIN AMERICA REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 126 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 127 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 128 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 129 INCREMENTAL GROWTH BY LATIN AMERICA 2021 & 2027

EXHIBIT 130 REMOTE PATIENT MONITORING MARKET IN MEXICO 2021–2027 ($ BILLION)

EXHIBIT 131 REMOTE PATIENT MONITORING MARKET IN ARGENTINA 2021–2027 ($ BILLION)

EXHIBIT 132 REMOTE PATIENT MONITORING MARKET IN BRAZIL 2021–2027 ($ BILLION)

EXHIBIT 133 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET: KEY COUNTRIES ($ BILLION)

EXHIBIT 134 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 135 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 136 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 137 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 138 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 139 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 140 REMOTE PATIENT MONITORING MARKET IN TURKEY 2021–2027 ($ BILLION)

EXHIBIT 141 REMOTE PATIENT MONITORING MARKET IN SAUDI ARABIA 2021–2027 ($ BILLION)

EXHIBIT 142 REMOTE PATIENT MONITORING MARKET IN SOUTH AFRICA 2021–2027 ($ BILLION)

EXHIBIT 143 MEDTRONIC REVENUE 2018-2021 ($ BILLION)

EXHIBIT 144 MEDTRONIC SEGMENT 2021 (%)

EXHIBIT 145 PHILIPS HEALTHCARE SEGMENT 2021 (%)

EXHIBIT 146 PHILIPS HEALTHCARE REVENUE 2018–2021 ($ BILLION)

EXHIBIT 147 PHILIPS HEALTHCARE REGIONAL REVENUE 2021 (%)

EXHIBIT 148 RESMED SEGMENT 2021 (%)

EXHIBIT 149 RESMED REVENUE 2018–2021 ($ BILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 COMPANIES OFFERING DIFFERENT TYPES OF RPM SYSTEMS

TABLE 4 INTERNET USERS IN LATIN AMERICA

TABLE 5 TOP REMOTE PATIENT MONITORING SOFTWARE IN BRAZIL 2022

TABLE 6 TELEMEDICINE SITES IN SOUTH AFRICA & APPLICATIONS

TABLE 7 MEDTRONIC: MAJOR PRODUCT OFFERINGS

TABLE 8 COVIDIEN PLC.: MAJOR PRODUCT OFFERINGS

TABLE 9 PHILIPS HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 10 RESMED: MAJOR PRODUCT OFFERINGS

TABLE 11 RESIDEO TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 12 HONEYWELL INTERNATIONAL: MAJOR PRODUCT OFFERINGS

TABLE 13 LIFESCIENCE TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 14 COFORGE: MAJOR PRODUCT OFFERINGS

TABLE 15 WITHINGS: MAJOR PRODUCT OFFERINGS

TABLE 16 MEDM: MAJOR PRODUCT OFFERINGS

TABLE 17 IHEALTHUNIFIEDCARE: MAJOR PRODUCT OFFERINGS

TABLE 18 QARDIO: MAJOR PRODUCT OFFERINGS

TABLE 19 100-PLUS: MAJOR PRODUCT OFFERINGS

TABLE 20 A&D COMPANY: MAJOR PRODUCT OFFERINGS

TABLE 21 ABBOTT: MAJOR PRODUCT OFFERINGS

TABLE 22 ALTUMVIEW SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 23 BIOTRONIK: MAJOR PRODUCT OFFERINGS

TABLE 24 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS

TABLE 25 BARDY DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 26 CARDIOMO CARE: MAJOR PRODUCT OFFERINGS

TABLE 27 CARDIOLOGS: MAJOR PRODUCT OFFERINGS

TABLE 28 DRAGERWERK AG: MAJOR PRODUCT OFFERINGS

TABLE 29 F. HOFFMANN-LA ROCHE.: MAJOR PRODUCT OFFERINGS

TABLE 30 ROCHE DIABETES CARE. MAJOR PRODUCT OFFERINGS

TABLE 31 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 32 GRANDCARE SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 33 MASIMO CORPORATION: MAJOR PRODUCT OFFERINGS

TABLE 34 MEDOPAD.: MAJOR PRODUCT OFFERINGS

TABLE 35 NIHON KOHDEN: MAJOR PRODUCT OFFERINGS

TABLE 36 OMRON HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 37 OSPLABS: MAJOR PRODUCT OFFERINGS

TABLE 38 SMITHS MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 39 SPACELABS HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 40 SENSEONICS: MAJOR PRODUCT OFFERINGS

TABLE 41 TELEMEDCARE: MAJOR PRODUCT OFFERINGS

TABLE 42 VITALCONNECT: MAJOR PRODUCT OFFERINGS

TABLE 43 VITLS: MAJOR PRODUCT OFFERINGS

TABLE 44 MODICARE: MAJOR PRODUCT OFFERINGS

TABLE 45 WELCH ALLYN: MAJOR PRODUCT OFFERINGS

TABLE 46 VIVIFY HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 47 ACL DIGITAL: MAJOR PRODUCT OFFERINGS

TABLE 48 DEXCOM: MAJOR PRODUCT OFFERINGS

TABLE 49 IRHYTHM TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 50 VIVALINK: MAJOR PRODUCT OFFERINGS

TABLE 51 BIOBEAT: MAJOR PRODUCT OFFERINGS

TABLE 52 CAREVALIDATE: MAJOR PRODUCT OFFERINGS

TABLE 53 BIOFOURMIS: MAJOR PRODUCT OFFERINGS

TABLE 54 CAREMINDR: MAJOR PRODUCT OFFERINGS

TABLE 55 DATOS HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 56 GLOBAL REMOTE PATIENT MONITORING MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)

TABLE 57 GLOBAL REMOTE PATIENT MONITORING MARKET BY GEOGRAPHY 2021−2027 (%)

TABLE 58 GLOBAL REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 59 GLOBAL REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)

TABLE 60 GLOBAL REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 61 GLOBAL REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 62 GLOBAL REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021–2027 ($ BILLION)

TABLE 63 GLOBAL REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 ($ BILLION)

TABLE 64 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 65 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)

TABLE 66 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 67 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 68 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 69 NORTH AMERICA REMOTE PATIENT MONITORING MARKET BY END-USER 2021–2027 ($ BILLION)

TABLE 70 EUROPE REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 71 EUROPE REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)

TABLE 72 EUROPE REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 73 EUROPE REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 74 EUROPE REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 75 EUROPE REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 ($ BILLION)

TABLE 76 APAC REMOTE PATIENT MONITORING MARKET BY COMPONENTS 2021−2027 ($ BILLION)

TABLE 77 APAC REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)

TABLE 78 APAC REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 79 APAC REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 80 APAC REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 81 APAC REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 ($ BILLION)

TABLE 82 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 83 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)

TABLE 84 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 85 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 86 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 87 LATIN AMERICA REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 ($ BILLION)

TABLE 88 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 89 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)

TABLE 90 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 91 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 92 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 93 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING MARKET BY END-USER 2021–2027 ($ BILLION)

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date